Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Tonatiuh Suárez Ramos"'
Autor:
Karen J. Ortiz‐Ortiz, Carlos R. Torres‐Cintrón, Tonatiuh Suárez Ramos, Maira A. Castañeda‐Avila, Luis A. Cotto Santana, Guillermo Tortolero‐Luna
Publikováno v:
Cancer Medicine, Vol 12, Iss 6, Pp 6889-6901 (2023)
Abstract Background The use of markers has stimulated the development of more appropriate targeted therapies for chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML). We assessed the use and prevalence of biological and genetic markers
Externí odkaz:
https://doaj.org/article/99037b09b7b34b03a868d255acc4de94
Autor:
Mariela Alvarado Ortiz, Tonatiuh Suárez Ramos, Carlos R Torres Cintrón, Diego Zavala Zegarra, Guillermo Tortolero Luna, Karen J Ortiz-Ortiz, Maira A Castaneda-Avila
Publikováno v:
PLoS ONE, Vol 18, Iss 5, p e0285547 (2023)
BackgroundLeukemia is a cancer of the early-forming cells. Over the past decade, leukemia racial/ethnic disparities have been documented in the United States of America (USA). Although the Puerto Rican population in the USA represents the second-larg
Externí odkaz:
https://doaj.org/article/406238850b2e4821bd801eb1952bda6d
Autor:
Maira A. Castaneda-Avila, Tonatiuh Suárez Ramos, Carlos R. Torres-Cintrón, Luis A. Cotto-Santana, Guillermo Tortolero-Luna, Karen J. Ortiz-Ortiz
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:e922-e930
Acute myeloid leukemia (AML) is the most common type of leukemia in adults. There are no previous studies evaluating AML treatment patterns in Puerto Rico. We describe the first-line therapy patterns and survival of patients diagnosed with AML in Pue
Autor:
Karen J. Ortiz‐Ortiz, Carlos R. Torres‐Cintrón, Tonatiuh Suárez Ramos, Maira A. Castañeda‐Avila, Luis A. Cotto Santana, Guillermo Tortolero‐Luna
Publikováno v:
Cancer medicineREFERENCES.
The use of markers has stimulated the development of more appropriate targeted therapies for chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML). We assessed the use and prevalence of biological and genetic markers of CLL and AML in t
Autor:
Karen J Ortiz-Ortiz, Guillermo Tortolero-Luna, Ruth Ríos-Motta, Alejandro Veintidós-Feliú, Robert Hunter-Mellado, Carlos R Torres-Cintrón, Tonatiuh Suárez-Ramos, Priscilla Magno
Publikováno v:
PLoS ONE, Vol 13, Iss 3, p e0194415 (2018)
This study aims to examine factors associated with the use of adjuvant chemotherapy and the use of oxaliplatin after curative resection in stage III colon cancer patients and assesses the effect of their use in three-year survival.This retrospective
Externí odkaz:
https://doaj.org/article/c078ee32025f4091a8a8519f853478ae
Autor:
Carlos R. Torres-Cintrón, Tonatiuh Suárez-Ramos, Maira A. Castañeda-Avila, Mara M. Epstein, Guillermo Tortolero-Luna, Karen J. Ortiz-Ortiz
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 32:C125-C125
Background: Multiple myeloma (MM) is an incurable malignancy of plasma cells. Overall 5-year survival rate has increased in recent years due to new treatments. However, this improvement has not been equal across sociodemographic groups. Older adults,